Latest News

As part of the London Tech Week 2026 Fringe Event, Nexus and Imperial College London convened founders and investors to share the hard-won lessons from the critical early years of building a venture.

Sixth formers from three Hammersmith & Fulham schools spent two days in Imperial College London’s chemistry labs on Wood Lane, getting a first-hand look at the world-class science careers on their doorstep.

The success of White City Innovation District took centre stage today as innovation leaders from across the globe gathered for the first ever Upstream London Network Economic Forum, held at ARC West London.

The Rt Hon Kanishka Narayan MP, Minister for Artificial Intelligence, gave a key speech on building Britain’s AI resilience at an Imperial event in WestTech London. That work is already underway in White City Innovation District.

Agilent Technologies and Imperial College London have renewed their successful advanced scientific instrument partnership for a further four years, extending the operation of the Agilent Measurement Suite (AMS) in White City Innovation District.

Imperial College London has been named University of the Year 2027 by The Times and Sunday Times Good University Guide. Imperial was also highly commended in the Russell Group University of the Year and named Medical School of the Year and University of the Year for Graduate Employment.

We caught up with Strategy Director Louis Glynn, Creative Director Michael Brightley, and Associate Director, Medical Copy, Steffi Evans from Langland to learn more about the thinking behind the work – and why White City Innovation District continues to spark fresh perspectives.

Imperial College London and South Korea’s Seoul AI Hub have signed a partnership to develop an AI research and technology programme. The collaboration will enable some of South Korea’s most promising startups to work closely with Imperial’s world-leading AI researchers.

Startups from White City Innovation District, one of the UK’s leading economic ecosystems for frontier innovation and future industries, have demonstrated their high-growth potential and strong appeal to investors – raising over £137 million within the first half of 2026. 

Our interview with Vizzy CEO Chris Woodward-Jones about the company’s journey, the future of recruitment in an AI-driven world – and why it’s never been more important to be human.

Imperial cancer therapy Myricx Bio has reached agreement to be acquired by Novartis – based in White City Innovation District – for up to $1.5 billion.

Pioneering biotech RQ Bio has announced an oversubscribed $115M (£85.5M) Series A round – the largest publicly announced UK Series A fundraise by a spinout this year.